Loading ARQT...
Arcutis Biotherapeutics Inc.ARQTAs of 31 July 2026
−300−1500+150+300
9
PositiveNegative
Equilibrium
CheapExpensive
FearGreed
WeakStrong
Asymmetry

Is Arcutis Biotherapeutics Inc. a good buy right now?

Whether Arcutis Biotherapeutics Inc. (ARQT) looks like a good buy comes down to three things: how it is valued, how the market feels about it, and how strong the underlying business is. Each is measured against Arcutis Biotherapeutics Inc.'s own five-year history, so you see genuine dislocation rather than noise. Information, not advice.

Arcutis Biotherapeutics Inc.ARQTLast 5 years
VEFA
ARQT priceasymmetryquant.com